Loading fund overlap…
4 of 110 unique stocks in common · Jaccard: 3.6%
A weighted portfolio overlap of 5.24% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.24 is allocated to the exact same companies at the same relative proportions. The schemes share 4 common holdings.
The largest overlapping asset in their portfolios is JB Chemicals & Pharmaceuticals, which commands a weight of 1.70% in Back to Index and 1.61% in Kotak Midcap Fund. Holding both schemes increases your concentration in JB Chemicals & Pharmaceuticals rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in Kotak |
|---|---|---|
| JB Chemicals & PharmaceuticalsPharmaceuticals & Biotechnology | 1.70% | 1.61% |
| Power Finance CorporationFinance | 1.56% | 1.64% |
| Poonawalla FincorpFinance | 1.06% | 1.16% |
| EternalRetailing | 1.01% | 2.04% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.